Gan Consulting Says No Asset Injection or Market Value Plan Exists, Denies Goldman Heavy Stake

Gan Consulting said that, as of the date of the announcement, it has no related asset injection plans or market value enhancement disclosure plans, and warned that the market was overinterpreting the matter. According to the company's shareholder information as of July 10, 2026, Goldman Sachs International held only a small stake in the stock. The company said recent media reports that Goldman Sachs was a heavy holder were seriously inaccurate and exaggerated, and do not match the actual situation, according to 36Kr.